$10M gift supports new myeloma research center at Ohio State
Virtual center will enable research sample sharing, collaborative multi-institutional research
Amanda Harper
A collaborative effort of the OSUCCC – James Drug Development Institute (DDI) and the Division of Hematology at Ohio State, this new center is focused on accelerating myeloma drug discovery and development projects at the OSUCCC – James. Initial projects will include the creation of a comprehensive, multi-institutional database for categorizing patient samples and correlating de-identified health data for future scientific studies aimed at better understanding and treatment of multiple myeloma.
This new financial support will enable the OSUCCC – James to accelerate drug discovery research to explore potential new treatments using specific molecular targets, including some identified by OSUCCC – James scientists. The gift will be made over the course of two years.